| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |